Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2020 07:05 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference and the RBC Capital Markets Global Healthcare Conference

WEST CHESTER, Pa., May 06, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases...
April 09, 2020 16:05 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Participate in the 19th Annual Needham Virtual Healthcare Conference

WEST CHESTER, Pa., April 09, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases...
March 13, 2020 07:00 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results

- New Drug Application for VP-102 for the treatment of molluscum contagiosum was accepted for filing by the U.S. Food and Drug Administration; assigned PDUFA goal date is July 13, 2020 - - Recently...
March 11, 2020 07:00 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Secures $55 Million in Loan Facilities Led by Silicon Valley Bank

WEST CHESTER, Pa., March 11, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases...
February 20, 2020 09:45 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Attend Several Upcoming Investor Conferences

WEST CHESTER, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases...
January 29, 2020 07:00 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Announces the Hiring of Two Vice Presidents to Further Grow its Commercial Capabilities

– Gerard DiGirolamo joins as Vice President, Sales,and Sheila Kennedy joins as Vice President, Marketing – – Extensive expertise and deep relationships in dermatology therapeutics will support...
January 18, 2020 10:00 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Announces Presentation of Positive Data from New Pooled Analysis of Phase 3 CAMP Trials of VP-102

- Analysis suggested statistically significantly higher lesion clearance with VP-102 compared to vehicle in all regions of the body, including those deemed most sensitive - - If approved, VP-102...
November 27, 2019 07:00 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

- PDUFA date assigned is July 13, 2020 - - VP-102 (cantharidin 0.7% Topical Solution) could potentially be the first FDA-approved treatment for molluscum contagiosum, a highly contagious viral skin...
November 25, 2019 07:00 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Announces Participation in the Piper Jaffray 31st Annual Healthcare Conference

WEST CHESTER, Pa., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a medical dermatology company committed to the development and commercialization of...
November 19, 2019 07:00 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Announces Passing of Board of Directors Member Glenn Oclassen

WEST CHESTER, Pa., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), announces with deep sadness the passing of Glenn Oclassen, a valued member of the...